Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
IPCALAB:NSE
IPCA Laboratories Ltd
₹1,540.00
-0.08%
(-1.30) 1D
Apr 28, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for IPCALAB...
Open
₹1,548.00
High
₹1,573.90
Low
₹1,530.20
Mkt. cap
390.70B
Avg. vol.
217.13K
Volume
99.42K
Dividend
0.26%
Quarterly dividend
₹1.00
Ex dividend date
Nov 22, 2023
P/E ratio
42.94
52-wk high
₹1,624.00
52-wk low
₹1,251.60
EPS
₹35.86
Shares outstanding
126.35M
No. of employees
17K
News stories
From sources across the web
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees16.8K
FoundedOct 19, 1949
Headquarters-
SectorPharmaceutical industry
Websiteipca.com
Last report
Feb 16, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
12.09/ (11.61 est.)INR
+4.10%beat
Revenue / Estimate
23.92B/ (24.79B est.)INR
-3.51%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
22.48B
23.09B
25.56B
23.92B
Cost of goods sold
10.11B
6.92B
7.82B
6.58B
Cost of revenue
10.11B
6.92B
7.82B
6.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.22B
5.43B
5.38B
5.46B
Operating expense
9.39B
13.01B
13.33B
13.09B
Total operating expenses
19.51B
19.92B
21.15B
19.67B
Operating income
2.98B
3.16B
4.42B
4.26B
Other non operating income
-609.20M
326.60M
278.60M
201.90M
EBT including unusual items
1.26B
3.29B
3.89B
4.46B
EBT excluding unusual items
2.82B
3.29B
4.47B
4.28B
Income tax expense
622.20M
960.90M
1.08B
819.30M
Effective tax rate
49.30%
29.21%
27.81%
18.39%
Other operating expenses
3.20B
6.58B
6.92B
6.55B
Net income
678.20M
2.33B
2.83B
3.26B
Net profit margin
3.02%
10.10%
11.05%
13.64%
Earnings per share
8.74
9.19
12.35
12.09
Interest and investment income
351.20M
-
-
-
Interest expense
-209.00M
-185.10M
-196.10M
-176.20M
Net interest expenses
142.20M
-185.10M
-196.10M
-176.20M
Depreciation and amortization charges
963.40M
1.00B
1.03B
1.08B
EBITDA
3.90B
4.09B
5.43B
5.18B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more